- Condition: Prophylaxis of Lyme Borreliosis
Interventions: Biological: Multivalent recombinant OspA Lyme Borreliosis Vaccine; Biological: Multivalent recombinant OspA Lyme Borreliosis Vaccine; Biological: Multivalent recombinant OspA Lyme Borreliosis Vaccine
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Recruiting - verified January 2012 - Condition: Lyme Borreliosis
Intervention: Drug: Doxycycline
Sponsors: University Medical Centre Ljubljana; University Medical Centre Ljubljana
Recruiting - verified November 2011 - Conditions: Erythema Migrans; Erythema Chronicum Migrans; Borreliosis; Lyme Disease; Early Lyme Disease
Interventions: Drug: Doxycycline; Drug: Phenoxymethylpenicillin; Drug: Amoxicillin
Sponsors: University of Oslo; University of Oslo; Norwegian Institute of Public Health; Sorlandet Hospital HF; Norwegian University of Life Sciences
Recruiting - verified April 2011 - Conditions: Lyme Disease; Borrelia Burgdorferi
Interventions: Procedure: Skin Biopsy; Device: Xenodiagnosis; Procedure: Blood Drawing
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Multiple Erythema Migrans
Interventions: Drug: ceftriaxone; Drug: doxycycline; Other: control subjects without a history of Lyme borreliosis; Other: erythema migrans patients treated with doxycycline
Sponsors: University Medical Centre Ljubljana; University Medical Centre Ljubljana
Recruiting - verified October 2011 - Condition: Nervous System Lyme Borreliosis
Intervention: Drug: ceftriaxone
Sponsors: University Medical Centre Ljubljana; University Medical Centre Ljubljana
Recruiting - verified October 2011 - Condition: Lyme Borreliosis
Intervention: Other: Cutaneous biopsy
Sponsors: University Hospital, Strasbourg, France; University Hospital, Strasbourg, France; Société Française de Dermatologie
Recruiting - verified March 2012 - Condition: Southern Tick-Associated Rash Illness
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Erythema Migrans Lesions; Erythema Migrans
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Lyme Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified June 2011 - Conditions: Chronic Disease; Healthy; Lyme Arthritis; Lyme Disease; Multiple Sclerosis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011


